Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun An
experimental antithrombotic .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word semuloparin.
Examples
-
WEDNESDAY, Feb. 15 HealthDay News -- A new blood-thinning medication called semuloparin reduces the risk of blood clots in people undergoing certain cancer treatments, new research shows.
-
One group received treatment with semuloparin, which is a type of heparin, while they were undergoing chemotherapy.
-
An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in
PhysOrg.com - latest science and technology news stories 2010
-
Throughout 2011, further newsflow from R&D is expected with Phase III studies expected to be completed/reported for five compounds currently in development lixisenatide, teriflunomide, aflibercept, ombrabulin, and semuloparin.
unknown title 2011
-
The incidence of any type of excessive bleeding was 2.8 percent for the semuloparin group and 2.0 percent in those on placebo.
-
Blood clots occurred in just 1.2 percent of those taking semuloparin compared to 3.4 percent of those on the placebo, according to the study.
-
Major bleeding occurred in 1.2 percent of those on semuloparin and 1.1 percent of those on placebo.
-
The follow-up analysis of three recently completed international clinical studies on short-term venous thromboembolism (VTE) protective medicine in patients undergoing major orthopedic surgery demonstrated that the ultra-low-molecular-weight heparin semuloparin reduced the incidence of VTE and all-cause death by 25 per cent compared to the commonly used therapy drug enoxaparin (a low-molecular-weight heparin).
PhysOrg.com - latest science and technology news stories 2010
-
The objective of the three studies was to assess once-daily preventative treatment with semuloparin (20 mg) compared to enoxaparin (40 mg daily in hip, and 30 mg twice-daily for knee) for seven to 10 days.
PhysOrg.com - latest science and technology news stories 2010
-
The SAVE program is supported by sanofi-aventis, producer of semuloparin.
PhysOrg.com - latest science and technology news stories 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.